Our company has been engaged in the development of measurement technology for completely non-contact, non-invasive blood testing information based on mathematical sciences for over a decade.
On August 29, 2025, we will present our technology at the national conference of the Japanese Society of Laboratory Medicine. Starting from the end of September 2025, we will also release our proprietary application ‘FLD HbA1c,’ which enables simultaneous estimation of HbA1c, pulse rate, and oxygen saturation, through our exclusive SFM App Store.
Recently, we announced a LDL cholesterol estimate application for Android, and we are pleased to report that the development for the iOS version has now been completed.
Demonstration of estimation conducted on an iPhone:
Similar to FLD HbA1c, this can be performed in a completely non-contact and non-invasive manner.
Moving forward, we will strive to further enhance precision as we prepare for general sales and other expansions.
We will inform you as soon as the details of the iOS version release are finalized.
Furthermore, we will provide updates as other application features are completed.